Overview
Vitamed Pharmaceuticals is a pharmaceutical company with exclusively Polish capital, offering medicinal products in gastroenterology, laryngology, dermatology, family medicine, urology and pediatrics. Its portfolio includes Gastrotuss, Rinopanteina, Immunotrofina plus vitamin D and Wortie products, along with patient materials on infant health, seasonal infections, reflux and kidney stones.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-06-23. Active
09 1240 3145 1111 0000 2779 8647- 27 1240 3145 1978 0010 0818 9748
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 14,627PLN 14,627 |
Public aid
12 public aid cases recorded, with a total value of $100,366.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 1, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $8,438$8,438 | Prezes Banku Gospodarstwa Krajowego | |
| Jul 31, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $4,788$4,788 | Prezes Banku Gospodarstwa Krajowego | |
| Jul 31, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $10,524$10,524 | Prezes Banku Gospodarstwa Krajowego |
Tenders
No recorded participation in tenders.
Trademarks
Vitamed Pharmaceuticals holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2025.
| Mark | Protected until | |
|---|---|---|
| PROSTABLOK URO | Oct 1, 2035 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The company is represented by the President of the Management Board independently, or by two members of the management board acting jointly, or by a member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marcin Piotr Har (63) | 1,000 | $270,124.26 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| AO East Europesp. z o.o. | $12,156,227.53 | aoeasteurope.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| SPA Landsp. z o.o. | $4,782,973.66 | hydrafacial.pl | ||
| Hair Partnerssp. z o.o. | $4,347,484.74 | hairpartners.pl | ||
| Balmed Polandsp. z o.o. | $3,140,735.80 | balmed.it | ||
| Medikon Polskasp. z o.o. | $2,666,944.24 | medikon.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-19 | Address change (Ul. Posła Józefa Ostrowskiego 24, 97-213, Smardzewice → Aleje Jerozolimskie 65/79/12.19, 00-697, Warszawa) | |
| 2020-06-23 | Entered in the register |
FAQ
Last updated: 2026-10-07